AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 154 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $853 | +308.1% | 275,000 | +83.3% | 0.83% | +235.5% |
Q1 2023 | $209 | -30.1% | 150,000 | 0.0% | 0.25% | -30.5% |
Q4 2022 | $299 | -99.9% | 150,000 | 0.0% | 0.36% | +5.6% |
Q3 2022 | $303,000 | -4.7% | 150,000 | +50.0% | 0.34% | 0.0% |
Q2 2022 | $318,000 | -44.3% | 100,000 | -20.0% | 0.34% | -36.1% |
Q4 2020 | $571,000 | – | 125,000 | – | 0.53% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fosun International Ltd | 21,521,301 | $83,503,000 | 7.34% |
Eversept Partners, LP | 2,656,208 | $10,306,087 | 2.29% |
TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $62,908,000 | 1.13% |
Prosight Management, LP | 512,659 | $1,989,000 | 0.95% |
THB ASSET MANAGEMENT | 833,104 | $3,232,000 | 0.90% |
GLOBEFLEX CAPITAL L P | 251,696 | $977,000 | 0.26% |
XTX MARKETS LLC | 10,243 | $40,000 | 0.19% |
HUSSMAN STRATEGIC ADVISORS, INC. | 102,000 | $396,000 | 0.10% |
PA Capital LLC | 33,874 | $132,000 | 0.09% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 60,900 | $236,000 | 0.07% |